Products
Research Areas
COVID-19
Resources
Login
Quick Order
Cart Cart lightblue
Login
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.


Fields marked with a * are required.

Login
Quick Order
Contact Us

Location


Corporate Headquarters

Vector Laboratories, Inc.
6737 Mowry Ave
Newark, CA 94560
United States

Telephone Numbers



Customer Service: (800) 227-6666 / (650) 697-3600


Contact Us



Additional Contact Details

Login
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.


Fields marked with a * are required.

Login
Quick Order
Catalog Number Size Price
LS-C786525-100 100 µg $511 
AIPL1 Antibody - Anti-AIPL1 mouse monoclonal antibody immunofluorescent staining of COS7 cells transiently transfected by pCMV6-ENTRY AIPL1.
AIPL1 Antibody - HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY AIPL1 (Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-AIPL1.
AIPL1 Antibody - HEK293T cells transfected with either overexpress plasmid (Red) or empty vector control plasmid (Blue) were immunostained by anti-AIPL1 antibody, and then analyzed by flow cytometry.
AIPL1 Antibody - Anti-AIPL1 mouse monoclonal antibody immunofluorescent staining of COS7 cells transiently transfected by pCMV6-ENTRY AIPL1.
AIPL1 Antibody - HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY AIPL1 (Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-AIPL1.
AIPL1 Antibody - HEK293T cells transfected with either overexpress plasmid (Red) or empty vector control plasmid (Blue) were immunostained by anti-AIPL1 antibody, and then analyzed by flow cytometry.
1 of 3
2 of 3
3 of 3

Monoclonal Mouse anti‑Human AIPL1 Antibody (clone OTI2D11, Carrier‑free, IF, WB) LS‑C786525

Monoclonal Mouse anti‑Human AIPL1 Antibody (clone OTI2D11, Carrier‑free, IF, WB) LS‑C786525

Antibody:
AIPL1 Mouse anti-Human Monoclonal (Carrier-free) (OTI2D11) Antibody
Application:
IF, WB, Flo
Reactivity:
Human
Format:
Unconjugated, Carrier-free
Other formats:
Price
Catalog Number
$511
LS-C786525-100
Toll Free North America
(800) 227-6666
For Research Use Only

Overview

Antibody:
AIPL1 Mouse anti-Human Monoclonal (Carrier-free) (OTI2D11) Antibody
Application:
IF, WB, Flo
Reactivity:
Human
Format:
Unconjugated, Carrier-free
Other formats:

Specifications

Description
AIPL1 antibody LS-C786525 is an unconjugated mouse monoclonal antibody to human AIPL1. Validated for Flow, IF and WB.
Target
Human AIPL1
Synonyms
AIPL1 | AIPL2 | LCA4
Host
Mouse
Reactivity
Human (tested or 100% immunogen sequence identity)
Clonality
IgG1 Monoclonal
Clone
OTI2D11
Conjugations
Unconjugated
Purification
Purified from ascites.
Modifications
Carrier-free. Also available Unmodified.
Immunogen
Full length human recombinant protein of human AIPL1(NP_055151) produced in HEK293T cell.
Applications
  • Immunofluorescence (1:100)
  • Western blot (1:2000)
  • Flow Cytometry (1:100)
Usage
Applications should be user optimized.
Presentation
PBS, pH 7.3, 8% Trehalose
Reconstitution
Reconstitute with PBS pH 7.3. To use this carrier-free antibody for conjugation experiment, we strongly recommend you to perform another round of desalting process.
Storage
Store at -20°C. Avoid freeze-thaw cycles.
Restrictions
For research use only. Intended for use by laboratory professionals.
Guarantee
This antibody carries the LSBio 100% Guarantee.
LSBio Guarantee
About AIPL1
Q9NZN9 NM_014336 NP_055151.3

Publications (0)

Customer Reviews (0)


Request SDS/MSDS

To request an SDS/MSDS form for this product, please contact our Technical Support department at:

Technical.Support@LSBio.com

Requested From: United States
Date Requested: 11/22/2024